Copy link Glucagon-Like Peptide 1 Receptor Agonists and Aspiration Risk Last updated: 08/23/2023 Key Points Glucagon-like peptide 1 receptor agonists (GLP-1-RA) are incretin hormones that help to lower blood sugar and aid in weight loss which has made them important medications for treatment in patients with type 2 diabetes mellitus (T2DM) and obesity
For Heart Health 2,000-4,000 milligrams per day Enhances heart function and decreases inflammation
Is there official FDA storage guidance for retatrutide
TL;DR GLP-1 drugs such as semaglutide, tirzepatide, and liraglutide can help reduce appetite and body weight, but emerging research shows they may also increase the risk of protein, vitamin, and mineral deficiencies, especially when appetite drops sharply and food intake becomes too low or too limited
Fatigue, muscle weakness, and even mood disorders like depression
This prioritisation process contributes to ensuring MPP focuses its efforts on medicines for which licensing could have the greatest public health impact